Australia Markets open in 9 hrs 2 mins

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0710-0.0010 (-1.39%)
At close: 01:25PM AEST
Currency in AUD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.1900
52-week low 30.0700
50-day moving average 30.0898
200-day moving average 30.1248

Share statistics

Avg vol (3-month) 3690.86k
Avg vol (10-day) 3454.2k
Shares outstanding 53.18B
Implied shares outstanding 6N/A
Float 81.09B
% held by insiders 161.33%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -185.43%
Operating margin (ttm)-192.12%

Management effectiveness

Return on assets (ttm)-18.92%
Return on equity (ttm)-31.85%

Income statement

Revenue (ttm)9.07M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)3,840.90%
Gross profit (ttm)3.07M
EBITDA -16.86M
Net income avi to common (ttm)-16.82M
Diluted EPS (ttm)-0.0060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.64M
Total cash per share (mrq)0.01
Total debt (mrq)673.6k
Total debt/equity (mrq)1.41
Current ratio (mrq)12.31
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-12.95M
Levered free cash flow (ttm)-7.16M